These success, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the strategy of targeting ACKR3 as a novel strategy to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-related disorders. These outcomes recommend that conolidine https://romaint728kbr3.sunderwiki.com/user